MiniMed Group, Inc. (MMED)
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Last price
- $19.21
- As of
Kresmion compiles this page from MMED's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
MiniMed Group, Inc. (MMED): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-16.
See the full MMED dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for MMED on one page. Preview it with sample data, then open it live with a free account.
Preview the MMED dossierActive events for MMED
- high13F: funds added
3 tracked funds increased MMED this 2026Q2, institutional consensus
- mediumEarnings below estimates
Q1-2027: Missed consensus by 100.0%, EPS $0.00 vs $0.0952 estimate
- medium13F: new position
CITADEL ADVISORS LLC new position in MMED
- high13F: large reduction
Point72 Asset Management, L.P. cut 99% of MMED (2026Q2)
- medium13F: new position
RENAISSANCE TECHNOLOGIES LLC new position in MMED
FREE, NO ACCOUNT
Every event on MMED, as it fires
You are seeing 5 of 13 events recorded on MMED since 2026-06-11.
The five above landed across 3 days. The other 8 were recorded on 2 other days. 8 of the 13 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in MMED (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLCCUSIP 60365F109 · 2026Q2 | $45.8M | 0.02% | , |
| CITADEL ADVISORS LLCCUSIP 60365F109 · 2026Q2 | $42.8M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 60365F109 · 2026Q2 | $1.3M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 60365F109 · 2026Q2 | $607K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 60365F109 · 2026Q2 | $230K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, MMED
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Kresmion Research Notes on MMED
MMED against its peers
MMED's operating margin of -6.1% ranks in the 42nd percentile of 17 Medical Instruments & Supplies sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | MMED | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 3.1B USD | 95.1M USD | 84 | 15 |
| Gross margin | 54.2% | 59.7% | 43 | 14 |
| Operating margin | -6.1% | 2.2% | 42 | 17 |
| Net margin | -10.7% | -4.8% | 36 | 17 |
| Return on equity | -9.2% | -3.4% | 44 | 16 |
Peers (18): STVN, ICUI, BLCO, BLFS, KMTS, ALC, AVR, EMBC, SMTI, OSUR, UTMD, PDEX, NNNN, ZJYL, KRMD, STXS, NYXH, MBOT. Left out: OBOCY (no annual filing), SHTPY (no annual filing), PLSE (no annual filing), AZTA (no annual filing), SOAGY (no annual filing), SDMHF (no annual filing), DAVI (no annual filing). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (MMED: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow MMED on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to MMED for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.